Maternal and Fetal Outcomes Associated With Infective Endocarditis in Pregnancy

Published On: 27 Aug, 2022 1:20 PM | Updated On: 21 May, 2024 10:30 PM

Maternal and Fetal Outcomes Associated With Infective Endocarditis in Pregnancy

Infective endocarditis (IE) is a rare but serious infection complicating pregnancy. However, its management and outcomes in this population remain unclear.

A recent study searched The National Readmissions Database to obtain the relevant data between October 2015 and October 2018. It identified admissions for IE in female patients of reproductive age using Billing codes. The study compared demographic characteristics, comorbidities, and outcomes between maternity-associated and nonmaternity-associated IE patients and obstetric patients who delivered with and without IE. 

The study identified 12602 reproductive-aged female patients with a diagnosis of IE, of which 382 were maternity-associated. 117 (among 382) occurred during a delivery admission. Contrasting the patients with nonmaternity-associated IE, maternity-associated infection was associated with younger age, Medicaid coverage, and drug use. However, the mortality was comparable. Contrasting with patients who delivered without IE, IE complicating delivery showed worse maternal and fetal outcomes, including maternal mortality and preterm birth.

Thus, Maternity-associated IE does not have an additional risk for adverse outcomes over nonmaternity-associated infection. Patients who deliver with IE have worse maternal and fetal outcomes than those not complicated by IE.

Dagher MM, Eichenberger EM, Addae-Konadu KL, Dotters-Katz SK, Kohler CL, Fowler VG, Federspiel JJ. Maternal and Fetal Outcomes Associated With Infective Endocarditis in Pregnancy. Clin Infect Dis. 2021 Nov 2;73(9):1571-1579. DOI: 10.1093/cid/ciab533. PMID: 34111290; PMCID: PMC8563217.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks